Skip to main content
HR 220 116th Congress House

National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019

Official title: To provide for a national strategy to address and overcome Lyme disease and other tick-borne diseases, and for other purposes.

Introduced: January 3, 2019 Introduced by: Smith, Christopher H. Republican · New Jersey See on congress.gov
Health Congressional oversightDepartment of Health and Human ServicesExecutive agency funding and structureHealth information and medical records
More subjectsShow fewer subjects
Health programs administration and fundingHealth promotion and preventive careInfectious and parasitic diseasesMedical educationMedical researchMedical tests and diagnostic methodsResearch administration and fundingScientific communication
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 25, 2019
Referred to the Subcommittee on Health.
Jan 3, 2019
Referred to the House Committee on Energy and Commerce.
Jan 3, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action January 25, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019

This bill establishes the Office of Oversight and Coordination for Tick-Borne Diseases within the Department of Health and Human Services (HHS). The office must oversee the creation of a national strategy to address Lyme disease and other tick-borne diseases and disorders. The national strategy must include program assessments, benchmarks for progress, and recommendations from the previously established Tick-Borne Disease Working Group.

The bill also requires HHS to undertake specific actions that promote research, prevention, and treatment of Lyme disease and other tick-borne diseases and disorders. Among other things, HHS must:

  • support expansive research into the pathology, diagnosis, and treatment of such diseases and disorders;
  • establish a surveillance system to track the prevalence of such diseases and disorders in humans;
  • establish a surveillance system to track the prevalence of disease-carrying ticks;
  • conduct educational campaigns; and
  • hold a series of research symposiums.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 220: National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-220/
MLA
"H.R. 220: National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-220/.
Bluebook (legal)
H.R. 220, 116th Cong. (2026), https://openamerica.io/bill/116-HR-220/.
Markdown link
[H.R. 220: National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019](https://openamerica.io/bill/116-HR-220/)
Report a problem